Continue the Conversation: Social Media at the AACR Annual Meeting
Guest Post by Raymond DuBois, MD, PhD Arizona State University Biodesign Institute
Guest Post by Raymond DuBois, MD, PhD Arizona State University Biodesign Institute
Guest Post by Cynthia Ryan, PhD Past Mentor in the AACR’s Scientist↔Survivor Program (SSP)
January is Cervical Cancer Awareness Month. Here's the latest on prevention, screening, and treatment.
Tamas A. Gonda, MD, 2014 recipient of the Landon Foundation-AACR INNOVATOR Award for Cancer Prevention Research, is examining how...
By Kaleem Zaidi, PhDAACR Executive Office The year 2022 marked significant progress against cancer, thanks to advances in cancer...
New imaging system can help surgeons get more cancer out; Presurgery chemo can make ovarian cancer responsive to immunotherapy...
We asked Eric Winer, MD, chief of the Division of Women's Cancers and director of the Breast Oncology Center...
The COVID-19 pandemic remains at the center of health and science news as cases of the disease continue to rise...
Anthracyclines, a widely used class of chemotherapeutics, work in several ways to kill rapidly dividing cells, including those found...
As the virtual 14th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved got underway...
The advent of immunotherapy has led to durable responses for an increasing number of patients, including many who initially...
Around 400 BC, the Greek physician Hippocrates is believed to have first described tumors as “cancer,” using the words...
Guest post by Ned Sharpless, MD, FAACR As I announced a short time ago, I have decided to step...
Experts identify opportunities and challenges facing cancer researchers in 2017.
Pediatric oncologist and precision medicine expert Andrew Kung, MD, PhD, of Columbia University explains.
Guest post by Keith Hornberger, PhD The AACR-Chemistry in Cancer Research (CICR) Working Group’s mission is to advocate the...
Assessing new anticancer therapeutics in clinical trials is a vital step in evaluating the toxicity and efficacy of treatment...
The term “cancer” encompasses a broad range of diseases that can afflict almost any organ of the body. Not only do molecular features...
Mubarak Labaran Liman has overcome the death of his father and a scarcity of resources to develop a thriving...
Scientific advancements are made through scientific research. From understanding the basic biology behind a disease to testing how well...
Outside the lab, Frank McCormick, PhD, FAACR, is a racecar driver, nurturing a passion he developed decades ago. (“We...
Although not as common as breast, prostate, or lung cancer, kidney cancer is one of the most frequently diagnosed...
Guest Post by Kelsey Hampton, BS Member of the AACR’s Associate Member Council-led Communications Committee
Early-career investigators play an important role in advancing cancer research, helping spur new discoveries and the translation of these...
In recognition of June as Cancer Immunotherapy Month, organized by our colleagues at the Cancer Research Institute (CRI), the...
For the past five years, cohorts of talented young researchers from around the world have participated in the AACR...
Clinical trials for dogs with cancer can extend the lives of our four-legged friends while revealing insights about cancer...
Researchers are finding early clinical success in developing more targeted treatments for bile duct cancer, also called cholangiocarcinoma.
During his Presidential Address at the AACR Annual Meeting 2024, Philip D. Greenberg discussed research driving immunotherapy forward.
New cervical cancer self-screening options and a portable blood test device could lead to changes in at-home cancer screening...